Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mind Medicine Mindmed Inc (NQ: MNMD ) 6.360 -0.060 (-0.93%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mind Medicine Mindmed Inc < Previous 1 2 3 4 5 6 7 8 9 ... 31 32 Next > Psychedelic Compound-Based Drug Stocks Portfolio: Up 17.5% In July; Down 19% MTD August 15, 2024 This article highlights the 4 largest market cap clinical-stage psychedelic compound-based drug discovery companies with their stock performances MTD, in July, their areas of focus, and their latest... Via Talk Markets MNMD Stock Earnings: Mind Medicine Misses EPS for Q2 2024 August 13, 2024 MNMD stock results show that Mind Medicine missed analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace MindMed Reports Second Quarter 2024 Financial Results and Business Updates August 13, 2024 From Mind Medicine Inc. Via Business Wire Psychedelics Company MindMed Prices Public Offering Aiming To Raise $75M August 12, 2024 Via Benzinga Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering August 09, 2024 From Mind Medicine (MindMed) Inc. Via Business Wire Mind Medicine (MindMed) Inc. Announces Proposed Public Offering August 09, 2024 From Mind Medicine (MindMed) Inc. Via Business Wire MindMed to Present at Canaccord Genuity’s 44th Annual Growth Conference August 06, 2024 From Mind Medicine Inc. Via Business Wire MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update August 06, 2024 From Mind Medicine Inc. Via Business Wire EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves July 31, 2024 Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy. Via Benzinga MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer July 29, 2024 From Mind Medicine Inc. Via Business Wire MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT) July 17, 2024 From Mind Medicine Inc. Via Business Wire Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,... Via Talk Markets 3 Psychedelic Stocks to Ride to the Moon and Beyond July 06, 2024 Psychedelic stocks are a hot, trending area of investment as the FDA continues to weigh regulatory considerations that will open the market. Via InvestorPlace Exposures Product Safety FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals July 04, 2024 Biotech stocks are on the verge of a comeback after a period of underperformance amid a wave of FDA approvals. Via InvestorPlace Exposures Product Safety Clinical-Stage BioTech Drug Stocks Declined 13% In June July 01, 2024 Our BioTech Drug Stocks Portfolio was DOWN 13.2% in June. Before proceeding read Via Talk Markets MindMed to be Included in Russell 2000® and Russell 3000® Indexes June 28, 2024 From Mind Medicine Inc. Via Business Wire Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M June 26, 2024 The initiative focuses on commercializing academic research aimed at preventing deadly fentanyl from reaching the brain. Via Benzinga Largest Clinical-Stage BioTech Drug Stocks Declined 6% June 22, 2024 Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they... Via Talk Markets MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference June 21, 2024 From Mind Medicine Inc. Via Business Wire MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD) June 20, 2024 From Mind Medicine Via Business Wire Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024 June 18, 2024 Discover top strong buy penny stocks, poised for impressive gains as market indices climb, offering unique opportunities. Via InvestorPlace Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why June 09, 2024 Stocks for companies developing psychedelic treatments fell last Wednesday after advisers to the Food and Drug Administration voted against a mental-health therapy using the drug MDMA. Via Talk Markets Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment June 05, 2024 FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision. Via Benzinga Exposures Product Safety What's Going On With MindMed And Psychedelic Stocks? June 05, 2024 Mind Medicine (MindMed) shares are trading lower Wednesday after a Food and Drug Administration (FDA) panel rejected the approval of MDMA therapy for people with post-traumatic stress disorder (PTSD).... Via Benzinga DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session June 05, 2024 Via Benzinga Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session June 05, 2024 Via Benzinga Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket June 05, 2024 Via Benzinga MindMed to Participate in June Conferences May 28, 2024 From Mind Medicine Inc. Via Business Wire Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week May 27, 2024 This article highlights the performances last week and MTD of the 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies along with their areas of focus in our... Via Talk Markets The Time Traveler’s Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034 May 23, 2024 These long-term stocks to buy may seem speculative today, but so did Nvidia in 2024 -- and they may match the chipmaker's returns by 2034. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 ... 31 32 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.